C5E:PA:PA- (EUR)

ETF | Others |

Last Closing

USD 120.08

Change

-0.66 (-0.55)%

Market Cap

USD 0.54B

Volume

708.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.06 (-0.13%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.60 (+0.31%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.31%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.65 (-0.27%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.15 (+0.48%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.15 (+0.30%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.16 (+0.35%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.27%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.46 (+0.40%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

+0.53 (+0.50%)

USD 4.29B

ETFs Containing C5E:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.86% 72% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.86% 71% C- 76% C+
Trailing 12 Months  
Capital Gain 17.29% 67% D+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.29% 66% D+ 76% C+
Trailing 5 Years  
Capital Gain 63.11% 73% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.11% 72% C 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.66% 71% C- 68% D+
Dividend Return 10.66% 70% C- 67% D+
Total Return N/A 12% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 10.79% 64% D 80% B-
Risk Adjusted Return 98.81% 97% N/A 96% N/A
Market Capitalization 0.54B 71% C- 72% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.